• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Fujitsu Partners with Paradigm for Enhanced Clinical Trials

by Fred Pennic 08/26/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Fujitsu today announced a series of initiatives aimed at attracting global clinical trials to Japan and addressing the issue of drug loss. 

– By partnering with pharmaceutical companies and medical institutions, Fujitsu is leveraging its expertise in technology and healthcare to create a more efficient and effective clinical trial environment.

Key Initiatives

  • Partnership with Paradigm: Fujitsu has formed a strategic partnership with Paradigm Health, a leading provider of clinical trial platforms. Together, they will leverage Fujitsu’s Healthy Living Platform and AI services to streamline the clinical trial process and facilitate data collection and analysis.
  • Patient-Centric Clinical Trials: Fujitsu is launching a new service that utilizes AI to automatically create clinical trial documents. This will help to simplify the process for medical institutions and patients, making it easier to participate in clinical trials.
  • Expanded Support: Fujitsu plans to expand its support for clinical trials beyond planning and implementation, addressing challenges throughout the entire process.

Addressing the Drug Loss Issue in Japan

Japan has faced a significant challenge in attracting global clinical trials, resulting in a gap between drugs available in other countries and those approved for use domestically. Fujitsu’s initiatives aim to address this issue by creating a more efficient and attractive environment for clinical trials in Japan.

The Benefits of Fujitsu’s Approach

By leveraging AI and advanced technology, Fujitsu’s initiatives offer several benefits:

  • Improved efficiency: Streamlined data collection and analysis can significantly accelerate the clinical trial process.
  • Enhanced patient engagement: Patient-centric clinical trials can make it easier for patients to participate and contribute to medical research.
  • Increased access to innovative treatments: By attracting more clinical trials to Japan, patients will have better access to new and promising treatments.

Paradigm is excited to be partnering with Fujitsu to maximize clinical trial efficiency in Japan. This collaboration will modernize the clinical trial model and provide unprecedented access to clinical trials for patients across Japan. The partnership will leverage Paradigm’s industry leading Platform and Fujitsu’s expansive healthcare solutions to increase clinical trial patient accrual, decrease overall drug development timelines and costs, while working to eliminate drug loss in Japan. We believe that this collaboration will establish Japan as an essential part of the global clinical trials and drug development ecosystem while ensuring that Japanese patients have equitable access to the best possible care options.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Trials

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |